KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

ClearPoint Neuro (CLPT) Equity Average (2018 - 2025)

Historic Equity Average for ClearPoint Neuro (CLPT) over the last 12 years, with Q3 2025 value amounting to $17.8 million.

  • ClearPoint Neuro's Equity Average fell 4173.85% to $17.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.8 million, marking a year-over-year decrease of 4173.85%. This contributed to the annual value of $23.3 million for FY2024, which is 1980.37% down from last year.
  • ClearPoint Neuro's Equity Average amounted to $17.8 million in Q3 2025, which was down 4173.85% from $19.9 million recorded in Q2 2025.
  • Over the past 5 years, ClearPoint Neuro's Equity Average peaked at $47.3 million during Q1 2022, and registered a low of $17.8 million during Q3 2025.
  • In the last 5 years, ClearPoint Neuro's Equity Average had a median value of $30.0 million in 2023 and averaged $31.3 million.
  • In the last 5 years, ClearPoint Neuro's Equity Average skyrocketed by 214372.86% in 2021 and then crashed by 4173.85% in 2025.
  • ClearPoint Neuro's Equity Average (Quarter) stood at $46.0 million in 2021, then fell by 16.51% to $38.4 million in 2022, then crashed by 41.03% to $22.6 million in 2023, then grew by 20.15% to $27.2 million in 2024, then tumbled by 34.52% to $17.8 million in 2025.
  • Its Equity Average was $17.8 million in Q3 2025, compared to $19.9 million in Q2 2025 and $22.7 million in Q1 2025.